A detailed history of Td Private Client Wealth LLC transactions in Novartis Ag stock. As of the latest transaction made, Td Private Client Wealth LLC holds 12,446 shares of NVS stock, worth $1.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
12,446
Previous 8,850 40.63%
Holding current value
$1.3 Million
Previous $942 Million 51.94%
% of portfolio
0.04%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

BUY
$106.13 - $120.89 $381,643 - $434,720
3,596 Added 40.63%
12,446 $1.43 Billion
Q2 2024

Aug 14, 2024

BUY
$92.57 - $107.37 $819,244 - $950,224
8,850 New
8,850 $942 Million
Q1 2024

Aug 16, 2024

SELL
$95.27 - $108.47 $97,747 - $111,290
-1,026 Reduced 8.6%
10,906 $1.05 Billion
Q4 2023

Aug 16, 2024

BUY
$92.27 - $101.54 $58,037 - $63,868
629 Added 5.56%
11,932 $1.2 Billion
Q3 2023

Aug 16, 2024

BUY
$94.73 - $105.13 $176,008 - $195,331
1,858 Added 19.67%
11,303 $1.15 Billion
Q2 2023

Aug 16, 2024

BUY
$92.52 - $104.91 $4,996 - $5,665
54 Added 0.58%
9,445 $953 Million
Q1 2023

Aug 16, 2024

SELL
$80.03 - $92.81 $252,574 - $292,908
-3,156 Reduced 25.15%
9,391 $864 Million
Q4 2022

Aug 16, 2024

BUY
$75.55 - $92.52 $57,720 - $70,685
764 Added 6.48%
12,547 $1.14 Billion
Q3 2022

Aug 16, 2024

SELL
$74.61 - $87.26 $240,468 - $281,238
-3,223 Reduced 21.48%
11,783 $896 Million
Q2 2022

Aug 16, 2024

BUY
$80.52 - $93.75 $141,393 - $164,625
1,756 Added 13.25%
15,006 $1.27 Billion
Q1 2022

Aug 16, 2024

SELL
$80.11 - $90.62 $290,158 - $328,225
-3,622 Reduced 21.47%
13,250 $1.16 Billion
Q4 2021

Aug 16, 2024

SELL
$79.7 - $88.13 $31,481 - $34,811
-395 Reduced 2.29%
16,872 $1.48 Billion
Q3 2021

Aug 16, 2024

BUY
$81.78 - $95.14 $688,342 - $800,793
8,417 Added 95.11%
17,267 $1.41 Billion
Q2 2021

Aug 16, 2024

BUY
$85.24 - $94.15 $304,562 - $336,397
3,573 Added 16.67%
25,010 $2.28 Billion
Q1 2021

Aug 16, 2024

SELL
$83.5 - $98.47 $118,486 - $139,728
-1,419 Reduced 6.21%
21,437 $1.83 Billion
Q4 2020

Aug 16, 2024

SELL
$78.07 - $94.43 $95,869 - $115,960
-1,228 Reduced 5.1%
22,856 $2.16 Billion
Q3 2020

Aug 16, 2024

SELL
$82.14 - $91.0 $744,763 - $825,097
-9,067 Reduced 27.35%
24,084 $2.09 Billion
Q2 2020

Aug 16, 2024

BUY
$80.93 - $91.1 $1.02 Million - $1.15 Million
12,619 Added 61.46%
33,151 $2.9 Billion
Q1 2020

Aug 16, 2024

BUY
$70.67 - $99.01 $226,709 - $317,624
3,208 Added 18.52%
20,532 $1.69 Billion
Q4 2019

Aug 16, 2024

BUY
$84.35 - $95.37 $714,781 - $808,165
8,474 Added 95.75%
17,324 $1.64 Billion

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.